Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-27 FAIRBAIRN EMILY Director Gift −724,637 0
2026-05-09 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +22,000 22,000
2025-12-22 FAIRBAIRN EMILY Director Grant or award +724,637 $1.38 $1000K 724,637
2025-05-08 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +63,150 63,150
2024-12-19 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +31,559 31,559
2024-10-04 FAIRBAIRN EMILY Director Purchase · Series C Warrants (right to buy) +3,038,743 3,038,743
2024-10-04 FAIRBAIRN EMILY Director Purchase · Pre-Funded Warrants (right to buy) +3,038,743 3,038,743
2024-06-12 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +33,650 33,650
2023-07-28 FAIRBAIRN EMILY Director Other disposition −4,111,958 0
2023-06-15 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +85,000 85,000
2022-08-16 FAIRBAIRN EMILY Director Purchase +789,473 $1.90 $1.5M 4,111,958
2022-06-01 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +13,500 13,500
2022-06-01 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +10,500 10,500
2021-08-03 FAIRBAIRN EMILY Director Conversion +83,124 91,336
2021-08-03 FAIRBAIRN EMILY Director Conversion +27,706 27,706
2021-08-03 FAIRBAIRN EMILY Director Conversion +3,222,485 3,222,485
2021-08-03 FAIRBAIRN EMILY Director Purchase +100,000 $10.00 $1.0M 3,322,485
2021-08-03 FAIRBAIRN EMILY Director Conversion · Series A Preferred Stock −75,588 0
2021-08-03 FAIRBAIRN EMILY Director Conversion · Series A Preferred Stock −25,195 0
2021-08-03 FAIRBAIRN EMILY Director Conversion · Series A Preferred Stock −2,930,332 0

Page 1 of 2 · 21 trades